EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic Factors Associated With Increased Mortality in Pediatric Veno‐Occlusive Disease Following Hematopoietic Cell Transplantation

Irina Zaidman iD, Natalie Barsoum, Ehud Even-Or iD, Miriam Daher, Adi Avniel Aran, Polina Stepensky, Aharon Gefen

Clinical Transplantation · 2024

DOI: 10.1111/ctr.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Irina Zaidman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Hepatic Veno-Occlusive Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatic veno‐occlusive disease (VOD) is a life‐threatening complication of hematopoietic cell transplantation (HCT) and is categorized as a transplant‐related, systemic endothelial disease. Severe VOD can lead to multi‐organ dysfunction (MOF) and is associated with a high mortality rate.

Objective

To evaluate the incidence of VOD in children after HCT and analyze the outcomes and risk factors associated with increased mortality. Study Design A retrospective cohort study of 1243 children with malignant and non‐malignant diseases who underwent HCT at two large pediatric centers over 20 years.

Results

One hundred one patients (8%) developed VOD post HCT. Most patients developed VOD post allogeneic HCT (76%) versus autologous (24%). The incidence of VOD was twice as high in children with malignant diseases compared to non‐malignant (68% vs. 32%). A much higher incidence of VOD occurred in patients after a busulfan‐based regimen versus total body irradiation‐based and treosulfan‐based, 73%, 18%, and 1%, respectively. The 100‐day survival rate of HCT patients with VOD was 69%. The overall survival rate of the entire group was 50%, showing improvement over the span of the study years, from 40% between 2000 and 2009 to 63% between 2010 and 2021 ( p = 0.022). Factors associated with increased mortality included infections before transplant ( p = 0.013), conditioning regimen ( p = 0.01), abnormal liver function ( p = 0.019), presence of ascites ( p = 0.008), MOF ( p < 0.001), and the need for admission to a pediatric intensive care unit ( p < 0.001). There was no significant difference in survival rates between children treated with defibrotide alone or with those treated with defibrotide and steroids (61% and 65%, respectively; p = 0.685).

Conclusions

Severe VOD in pediatric patients following HCT remains a life‐threatening complication with a high mortality rate. Early diagnosis and treatment with defibrotide are critical for managing this condition. In our cohort, the addition of steroids to defibrotide was not associated with improved outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationHepatic Veno-Occlusive DiseaseHumansChildFemaleMaleRetrospective StudiesPrognosisChild, PreschoolAdolescentRisk FactorsInfantSurvival RateFollow-Up StudiesGraft vs Host DiseaseIncidenceTransplantation ConditioningYoung AdultPolydeoxyribonucleotides

Stichwörter der Autor:innen

childrenhematopoietic cell transplantationhepatic veno‐occlusive disease/sinusoidal obstruction syndromemalignant and nonmalignant diseasessurvival

Substanzen

defibrotidePolydeoxyribonucleotides

Autor:innen und Institutionen

  • Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Division of Pediatric Critical Care, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Division of Pediatric Hematology Oncology and Bone Marrow Transplantation, Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel.

ORCID-Profile: Irina Zaidman, Ehud Even-Or

Zitieren

APA

Zaidman, I., Barsoum, N., Even-Or, E., Daher, M., Aran, A. A., Stepensky, P., & Gefen, A. (2024). Prognostic Factors Associated With Increased Mortality in Pediatric Veno‐Occlusive Disease Following Hematopoietic Cell Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70037

Vancouver

Zaidman I, Barsoum N, Even-Or E, Daher M, Aran AA, Stepensky P, et al. Prognostic Factors Associated With Increased Mortality in Pediatric Veno‐Occlusive Disease Following Hematopoietic Cell Transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.70037

BibTeX
@article{Zaidman2024,
  author = {Zaidman, Irina and Barsoum, Natalie and Even-Or, Ehud and Daher, Miriam and Aran, Adi Avniel and Stepensky, Polina and Gefen, Aharon},
  title = {Prognostic Factors Associated With Increased Mortality in Pediatric Veno‐Occlusive Disease Following Hematopoietic Cell Transplantation},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.70037}
}
Kostenlos starten →